← FDA Drug Approvals (Drugs@FDA)
BENDAMUSTINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2019-02-20
Drug application
- FDA Application #
ANDA204771- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BENDAMUSTINE HYDROCHLORIDE
- Generic name
- Bendamustine Hydrochloride
- Active ingredients
- BENDAMUSTINE HYDROCHLORIDE
- Dosage form
- POWDER
- Route
- IV (INFUSION)
- Marketing status
- None (Tentative Approval)
- Sponsor
- GLENMARK PHARMS LTD
- First approval
- 2019-02-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown